ストックスクリーナーアプリを入手
1.47
0.00%
0.00
前日終値:
$1.47
開ける：
$1.48
24時間の取引高:
3.46M
Relative Volume:
0.45
時価総額：
$497.63M
収益：
$4.47M
当期純損益:
$-71.67M
株価収益率:
-6.3417
EPS:
-0.2318
ネットキャッシュフロー:
$-59.58M
1週間 パフォーマンス:
-2.65%
1か月 パフォーマンス:
+23.53%
6か月 パフォーマンス:
-2.00%
1年 パフォーマンス:
+27.83%
1日の値動き範囲:
$1.405
$1.49
1週間の範囲:
$1.405
$1.53
52週間の値動き範囲:
$0.931
$2.725
Ocugen Inc Stock (OCGN) Company Profile
Compare OCGN vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.47 | 497.63M | 4.47M | -71.67M | -59.58M | -0.2318 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-17 | 開始されました | Canaccord Genuity | Buy |
| 2026-03-11 | 開始されました | Oppenheimer | Outperform |
| 2024-10-15 | 開始されました | Maxim Group | Buy |
| 2023-03-01 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | 開始されました | Mizuho | Buy |
| 2022-06-15 | 再開されました | ROTH Capital | Buy |
| 2022-06-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-07-26 | 開始されました | Noble Capital Markets | Outperform |
| 2021-06-11 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2021-05-07 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | アップグレード | H.C. Wainwright | Neutral → Buy |
すべてを表示
Ocugen Inc (OCGN) 最新ニュース
Ocugen Eyes 3 Retinal Gene Therapy Filings as Late-Stage Pipeline Advances - Yahoo Finance
Ocugen at Piper Sandler ophthalmology day: gene therapy push advances By Investing.com - Investing.com Canada
Ocugen at Piper Sandler ophthalmology day: gene therapy push advances - Investing.com
Ocugen Inc. stock falls Thursday, underperforms market - MarketWatch
Ocugen’s Triple-Threat Pipeline: A $130M Cash Injection and a Summer of Make-or-Break Data - Ad-hoc-news.de
OCGN Stock Rallies On Wall Street Optimism For Clinical Pipeline: Retail Awaits New Data - Stocktwits
Ocugen stock stays tied to pipeline progress. Nasdaq listing keeps the US angle clear. - Ad-hoc-news.de
Ocugen Inc. stock falls Monday, underperforms market - MarketWatch
Why Did OCGN Stock Rise Today? - Stocktwits
Ocugen Inc. stock rises Thursday, outperforms market - MarketWatch
Ocugen Inc. stock falls Wednesday, underperforms market - MarketWatch
Ocugen to Participate in Upcoming July Industry Conferences - The Manila Times
Ocugen’s July retina conference talks include OCU410 phase 2 results - Stock Titan
Ocugen Inc. stock falls Tuesday, underperforms market - MarketWatch
Ocugen, Inc. pursues gene therapy innovation to address rare vision loss conditions - Traders Union
Ocugen Inc. stock rises Monday, outperforms market - MarketWatch
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2500 Growth Benchmark - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2000 Index - marketscreener.com
OCGN Stock Grinds Higher As Traders Track Tight Range - StocksToTrade
Ocugen’s CFO Makes a Rare Open-Market Buy as Institutional Investors Pile In Ahead of Key Gene The - AD HOC NEWS
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2000 Value Benchmark - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Microcap Value Benchmark Index - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2000 Growth Benchmark - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 3000E Growth Benchmark - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 3000E Index - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Microcap Index - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 3000E Value Benchmark - marketscreener.com
Ocugen Inc. stock rises Friday, outperforms market - MarketWatch
OCGN Stock Holds Buy Rating As Analyst Sees Key Catalysts Ahead - StocksToTrade
Enterprise value to EBITDA forward of Ocugen, Inc. – NASDAQ:OCGN - TradingView
Has Ocugen's Recent Convertible Notes Offering Stabilized Its Financial Future - Kavout | AI
Price to book forward of Ocugen, Inc. – NASDAQ:OCGN - TradingView
Ocugen Inc Actuals & Estimates (NASDAQ:OCGN) - TradingView
Price to book forward of Ocugen Inc – SWB:2H51 - TradingView
Ocugen Inc (OCGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Enterprise value to revenue forward of Ocugen, Inc. – NASDAQ:OCGN - TradingView
Ocugen's gene-agnostic eye therapies could reshape late-stage care - MSN
Price to earnings forward of Ocugen, Inc. – NASDAQ:OCGN - TradingView
Price to sales forward of Ocugen Inc – SWB:2H51 - TradingView
Enterprise value to EBIT forward of Ocugen Inc – SWB:2H51 - TradingView
Price to earnings forward of Ocugen Inc – SWB:2H51 - TradingView
OCGN Forecast — Price Target — Prediction for 2027 - TradingView
Ocugen: Financing Risk Is Lower, But The Clinical Bet Still Has To Work - Seeking Alpha
Ocugen (OCGN) Stock Draws Fresh Price Target Split After Cautious Analyst View - Yahoo Finance
Ocugen Inc (OCGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ocugen Inc. stock rises Tuesday, outperforms market - MarketWatch
OCGN Stock Holds Buy Rating As Analyst Trims Price Target - StocksToTrade
Ocugen completes OCU400 Phase 3 enrollment, shares trade in tight NASDAQ range - Ad-hoc-news.de
Ocugen Inc (OCGN) 財務データ
収益
当期純利益
現金流量
EPS
Ocugen Inc (OCGN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Zhang Junge | Director |
Apr 01 '26 |
Option Exercise |
0.79 |
194,134 |
154,303 |
1,359,316 |
2.64%
大文字化:
|
ボリューム (24 時間):